Tumor cell dormancy as an adaptive cell stress response mechanism [version 1; referees: 4 approved]

Abstract

Metastases are responsible for most cancer-related deaths. The kinetics of tumor relapse is highly heterogeneous, ranging from recurrences shortly after diagnosis to years or even decades after the initial treatment. This subclinical period is known as tumor dormancy, in which residual disease remains in an undetectable state before finally appearing as an overtly proliferative metastasis. Despite recent advances in our understanding of the molecular mechanisms leading to tumor dormancy, it is still a poorly understood phase of cancer progression, which limits opportunities for the design of successful therapeutic interventions. The influence of the tumor microenvironment at the metastatic site and anti-metastatic immune responses have been shown to play a crucial role in the onset and maintenance of metastatic dormancy. However, there is still a significant gap in our understanding of how dormant cells remain viable in a quiescent state for long periods of time. Here, we review the latest experimental evidence shedding light on the biological processes that enable dormant tumor cells to endure the multiple stresses encountered at the metastatic site.

Keywords

• Aging
• Breast Diseases: Benign & Malignant
• Cancer Therapeutics
• Cell Adhesion
• Cell Growth & Division
• Cell Signaling
• Cellular Death & Stress Responses
• Drug Discovery & Design
• Epidemiology
• Gynecological Cancers
• Head & Neck Cancers
• Innate Immunity
• Lung Cancer
• Stem Cells & Regeneration